Effects of Anti-Vascular Endothelial Growth Factor Drugs Before and After Pars Plana Vitrectomy in Patients with Polypoidal Choroidal Vasculopathy and Vitreous Hemorrhage
- Resource Type
- Authors
- Quan-Yong Yi; Jinghai Mao; Xiangxiang Fu; Li-Shuang Chen; Linghui Qu; Qian Gui; Sang-Sang Wang; Yanyan Wang; Wendie Li
- Source
- Journal of Ocular Pharmacology and Therapeutics. 37:591-596
- Subject
- Male
Pars plana
medicine.medical_specialty
Visual acuity
genetic structures
medicine.medical_treatment
Visual Acuity
Vitrectomy
Postoperative Complications
Ophthalmology
medicine
Humans
Pharmacology (medical)
Aged
Retrospective Studies
Aflibercept
Aged, 80 and over
Pharmacology
Vascular Endothelial Growth Factors
business.industry
Perioperative
Middle Aged
Macular degeneration
medicine.disease
Choroidal Neovascularization
Vitreous Hemorrhage
medicine.anatomical_structure
Vitreous hemorrhage
Female
Ranibizumab
medicine.symptom
business
medicine.drug
- Language
- ISSN
- 1557-7732
1080-7683
Purpose: To compare the clinical effects of postoperative versus perioperative injection of anti-vascular endothelial growth factor (VEGF) drugs before and after pars plana vitrectomy (PPV) in pati...